Skip to main content
Log in

Gaucher disease: Variability in phenotype among siblings

  • Published:
Journal of Inherited Metabolic Disease

Abstract

Summary: Although many mutations of the GBA gene have been described as causing Gaucher disease, there is generally poor correlation between genotype and phenotype, with a few exceptions. However, most previous reports of genotype–phenotype correlation have involved unrelated individuals, who, even if they share the same mutations, are not as genetically close as siblings. We havestudied 24 groups (mostly pairs) of Canadian siblings with type I (non-neuronopathic) Gaucher disease. Since most Canadian provinces have adopted similar criteria for instituting enzyme replacement therapy (ERT), the age at which ERT is begun can serve as a rough surrogate for disease severity, and concordance (or lack of concordance) can be examined between siblings. In 14 of the 24 sibling families, there was sibling concordance: either both siblings were not on ERT, or both were on ERT and had begun at roughly the same age. In these families, there was also much similarity in the clinical features of the disease between siblings. In the other 10 families there was lack of sibling concordance, with only one sibling receiving ERT (or, in one family with three affected siblings, two of three on ERT). In these families, there was also much discrepancy between siblings in the clinical features (as might be expected in a setting where the guidelines for starting ERT are relatively uniform). Possible reasons for thediscordances between siblings include macro-environmental and micro-environmental differences. The latter may include micro-environments at the level of the cell (e.g. lysosomal pH, alternative substrates) or at the level of the chromosome (contiguous genes, modifier genes, neutral polymorphisms in GBA).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  • Arceci RJ, Grabowski GA (2003) Histiocytoses and disorders of the reticuloendothelial system.In: Handin RI, Lux SE, Stossel TP, eds. Blood: Principles and Practice of Hematology, 2nd edn. Philadelphia: Williams and Wilkins, 921–957.

    Google Scholar 

  • Beutler E (2001a) Lipid storage diseases. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U, eds. Williams Hematology, 6th edn. New York: McGraw-Hill, 899–908.

    Google Scholar 

  • Beutler E (2001b) Discrepancies between genotype and phenotype in hematology: an important frontier. Blood 98: 2597–2602.

    Google Scholar 

  • Clarke JTR, Amato D, Deber RB (2001) Managing public payment for high-cost, high-benefit treatment: enzyme replacement therapy for Gaucher's disease in Ontario. CMAJ 165: 595–596.

    Google Scholar 

  • Germain DP, Puech J-P, Caillaud C, Kahn A, Poenaru L (1998) Exhaustive screening of the acid b-glucosidse gene, by £uorescence-assisted mismatch analysis using universal primers: mutation profile and genotype/phenotype correlations in Gaucher disease. Am J Hum Genet 63: 415–427.

    Google Scholar 

  • Hodanova K, Hrebicek M, Cervenkova M, Mrazova L, Veprekova L, Zeman J (1999) Analysis of the b-glucocerebrosidase gene in Czech and Slovak Gaucher patients: mutation profile and description of six novel mutant alleles. Blood Cells Mol Dis 25: 287–298.

    Google Scholar 

  • Koprivica V, Stone DL, Park JK, et al (2000) Analysis and classification of 3304 mutant alleles in patients with type 1 and type 3 Gaucher disease. Am J Hum Genet 66: 1777–1786.

    Google Scholar 

  • Laosombat V (1985) Acute neuronopathic (type 2) Gaucher disease in siblings in southern Thailand. J Med Assoc Thailand 68: 92–98.

    Google Scholar 

  • MacKenzie JJ, Amato D, Clarke JTR (1998) Enzyme replacement therapy for Gaucher's disease: the early Canadian experience. CMAJ 159: 1273–1278.

    Google Scholar 

  • Nilsson O, Grabowski GA, Ludman MD, Desnick RJ, Svennerholm L (1985) Glycosphingolipid studies of visceral tissue and brain from type 1 Gaucher disease variants. Clin Genet 27: 443–450.

    Google Scholar 

  • Orvisky E, Park JK, LaMarca ME, et al (2002) Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype. Mol Genet Metab 76: 262–270.

    Google Scholar 

  • van Weely S, Van den berg M, Barranger JA, Sa Miranda MC, Tager JM, Aerts JMFG (1993) Role of pH in determining the cell type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease. J Clin Invest 91: 1167–1175.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Amato, D., Stachiw, T., Clarke, J.T.R. et al. Gaucher disease: Variability in phenotype among siblings. J Inherit Metab Dis 27, 659–669 (2004). https://doi.org/10.1023/B:BOLI.0000042983.60840.f3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:BOLI.0000042983.60840.f3

Keywords

Navigation